Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma

Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma

Aim. To assess the prognostic value of clinical and hematological parameters used by hematologists for risk stratification in diffuse large B-cell lymphoma (DLBCL), and to justify the need for discovering new prognostic factors. Methods. The trial included 101 patients (48 men and 53 women) with...

Full description

Bibliographic Details
Main Authors: SV Samarina, EL Nazarova, NV Minaeva, EN Zotina, IV Paramonov, SV Gritsaev
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2018-12-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
diffuse large B-cell lymphoma
prognosis
induction therapy
survival
Online Access:http://bloodjournal.ru/wp-content/uploads/2018/12/9-1.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2018/12/9-1.pdf

Similar Items